![Yahoo! News](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/032/normal/yahoo_news.png?1369846922)
Coronavirus treatments: what drugs might work against COVID-19?
Yahoo! News,
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors…
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors…
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors…
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors…
The Covid-19 outbreak that Biogen execs unwittingly fostered during their annual strategy meeting at the Boston Marriott Long…
1. In this study, nearly 70% of patients who received remdesivir for compassionate use had an improvement in oxygen-support…
Two-thirds of seriously sick COVID-19 patients saw their condition improve after receiving the experimental drug Remdesivir…
The race for a COVID-19 vaccine is on, and as the disease continues to upend societies around the world, public health…
HOUSTON-(April 16, 2020) - COVID-19 patients in a clinical trial at Houston Methodist Hospital are responding quickly to the…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
Two-thirds of seriously sick COVID-19 patients saw their condition improve after receiving the experimental drug Remdesivir…
Credit: Science The RNA-dependent RNA polymerase of the novel coronavirus is a complex that includes the small proteins nsp7…
On March 19, 2020, President Trump touted the anti-malaria drug chloroquine as a possible "game changer" in the fight against…
Twitter lit up Wednesday afternoon after Bloomberg put out a story that a deal-hungry Gilead was in the hunt to buy a stake in…
A trial of Gilead's coronavirus symptom-treating antiviral drug candidate remdesivir is halted in China.
NBC News medical correspondent Dr. Natalie Azar has been sharing her experiences with coronavirus with TODAY.
Get the latest from TODAY NBC News medical correspondent Dr. Natalie Azar has been sharing her experiences with coronavirus…
Get the latest from TODAY NBC News medical correspondent Dr. Natalie Azar has been sharing her experiences with coronavirus…
The Dow Jones Industrial Average dove more than 700 points Wednesday midday on corporate earnings results and plunging retail…
After having to halt enrollment in its severe COVID-19 trial due to a lack of patients, a second test of Gilead’s old Ebola…
Shares of Gilead took a 3% hit $GILD Wednesday after researchers noted that they had suspended one of the closely-watched Covid-1…
CORONAVIRUS - “L’épidémie de coronavirus est en train de disparaître progressivement à Marseille”.
Click here for the latest coronavirus news, which the BDN has made free for the public.
U.S. Army medical officials say they have successfully treated two soldiers diagnosed with the novel coronavirus, using an…
The race for a COVID-19 vaccine is on, and as the disease continues to upend societies around the world, public health…
Slutreplik från Stefan Einhorn om strategin mot coronaviruset Publicerad: 15 april 2020 kl.
Molti dei dati attuali sui potenziali benefici di diversi farmaci in sperimentazione provengono da studi di laboratorio.
Tıp dünyası corona virüsünün neden olduğu COVID-19'un tedavisine odaklandı. Bu çalışmalarla ilgili Almanya, ABD ve Danimarka'dan…
(Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected…
As the death toll inches closer to 150,000, researchers across the globe are racing against the clock to develop an effective…
-- A small study of the antiviral drug remdesivir has shown that a majority of hospitalized patients with COVID-19 who took it…
New data on the investigational antiviral drug remdesivir (Gilead) suggest clinical improvement in 36 of 53 patients (68%…
GlaxoSmithKline and Sanofi turned a few heads today as the two giant vaccine rivals joined hands and technologies as they set…
I n early April, about four months after a new, highly infectious coronavirus was first identified in China, an international…
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international…
What your doctor is reading on Medscape.com: APRIL 13, 2020 -- Dear Gilead Leaders, Congratulations on developing the antiviral…
Galidesivir, not berotralstat, will be the BCRX catalyst Oral berotralstat is soon likely to gain approval in three regions …
Five years after turning his stake in Pharmacyclics into a personal fortune worth more than a billion dollars, Bob Duggan is…
Dans une nouvelle vidéo diffusée ce mardi, le professeur marseillais Didier Raoult s'est montré optimiste quant à la suite du…
Thousands of scientists around the world are working on problems raised by the COVID-19 pandemic.
S'identifier Rechercher Le Remdesivir confirme ses promesses. D'après une étude américaine, les patients atteints de formes sévèr…
Unfortunately, there hasn't been very much good news so far in the battle against novel coronavirus disease COVID-19.
The big biotech reported some encouraging results for its antiviral drug. But it's still too early to get excited.
Back in November, when the execs at Moderna laid plans for today’s day-long dive on their vaccine portfolio and plans, the…
With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected in China late…
With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected in China late…
Thousands of scientists around the world are working on problems raised by the COVID-19 pandemic.
Latest Coronavirus News By Zosia Chustecka April 13, 2020 -- New data on the investigational antiviral drug remdesivir (Gilead…
(Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected…
【健康醫療網/記者蔡岳宏報導】「這是目前最有機會的臨床藥物!」《新英格蘭醫學雜誌》10日公布「瑞德西韋」恩慈試驗初步結果,68%新冠肺炎重症患者獲得改善,總死亡率僅13%,中央流行疫情指揮中心張上淳教授肯定「有正面的效果」。開發該藥物藥廠的台灣分公司醫學總監…
【健康醫療網/記者蔡岳宏報導】「這是目前最有機會的臨床藥物!」《新英格蘭醫學雜誌》10日公布「瑞德西韋」恩慈試驗初步結果,68%新冠肺炎重症患者獲得改善,總死亡率僅13%,中央流行疫情指揮中心張上淳教授肯定「有正面的效果」。開發該藥物藥廠的台灣分公司醫學總監…
The Indian Council of Medical Research has said that it is considering using remdesivir, an antiviral drug developed by Gilead…
Eight additional patients were left out of the analysis: one due to a dosing error and seven because no information was…
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
- Monday, April 13th, 2020 Print |Email Gilead's drug remdesivir, a front-running COVID-19 treatment, was shown to effectively…
Results from a recent cohort analysis of 53 patients hospitalized with severe complications of coronavirus disease 2019 (COVID-19…
A small trial of an experimental antiviral drug that could treat COVID-19 patients has shown encouraging results, Cedars-Sinai…
By Christine Soares (Reuters) – With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that…
B y Christine Soares April 13 (Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV…
By Christine Soares April 13 (Reuters) – With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2…
By (Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first…
With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected in China late…
(Adds graphic link: https://reut.rs/3bhMUaE) By Christine Soares April 13 (Reuters) - With much of the world living in lockdown…
By Christine Soares April 13 (Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2…
By Christine Soares April 13 (Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2…
In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral…
By Jaimy Lee There's a lot of hope riding on remdesivir, which is being studied in multiple trials in the U.S.
A provincial trial is set to begin in Alberta to investigate the effectiveness of hydroxychloroquine, a drug normally used for…
Improvement in oxygen-support status was observed in 68 percent of patients hospitalized with severe coronavirus disease 2019…
First Posted: Apr 13, 2020 01:18 PM EDT (Photo: Reuters) Due to the escalating number of cases around the globe (a whopping 1.8…
A new study shows that remdesivir, an experimental antiviral drug, may help lower the risk of death for people with serious…
(HealthDay News) -- Improvement in oxygen support status was observed in 68 percent of patients hospitalized with severe…
The Dow Jones Industrial Average fell more than 600 points Monday morning, as the total number of U.S.
It had been a business professor’s idea, back before Christmas, when the most infectious threat facing the US was a potentially…
When Olivier Brandicourt joined Alnylam’s board two months ago, CEO John Maraganore highlighted how the former Sanofi chief’s…
) -- In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral…
.newsblock { width: 200px; height:200px; float:right; padding-left:15px; padding-right:15px; } LOS ANGELES (April 11, 2020) -…
Credit: CC0 Public Domain In a small group of patients hospitalized with severe complications of COVID-19 and treated with the…
In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral…
/dpa Los Angeles Von den ersten COVID-19-Patienten, die bis Anfang Mrz im Rahmen von Heilversuchen mit dem Virustatikum…
By Deena Beasley (Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment…
News Professional MONDAY, April 13, 2020 -- Improvement in oxygen support status was observed in 68 percent of patients…
Gilead Sciences has posted data on 53 severe COVID-19 patients who received remdesivir on a compassionate use basis.
Post Views: 2 LOS ANGELES (April 11, 2020) — In a small group of patients hospitalized with severe complications of COVID-19…
The coronavirus disease (COVID-19) has no approved treatment or vaccine as the world grapple with its wrath.
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for…
Már Kristjánsson, yfirlæknir á smitsjúkdómadeild Landspítalans. Ljósmynd/Skjáskot „Þetta er veirulyf sem er upphaflega þróað…
As the world continues to contend with the pandemic of coronavirus, medical experts arequicklyworking to find a cure or…
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug…
GMT +0300 More than two-thirds of severely ill Covid-19 patients saw their condition improve after treatment with remdesivir…
Health 0 Views The concerned doctors stood together after their rounds and weighed the risks.
This New York City hospital has been one of the hardest hit by the coronavirus.
The worried doctors stood together after their rounds, weighing the risks. A 31-year-old pregnant woman was in peril, her lungs…
Ce nouveau test sur un médicament candidat, le remdesivir, développé au départ contre le virus Ebola, et utilisé ici en usage…
JawaPos.com – Mayoritas dari sekelompok kecil pasien yang diobati dengan obat eksperimental Remdesivir untuk korona (Covid-19)…
The worried doctors stood together after their rounds, weighing the risks. A 31-year-old pregnant woman was in peril, her lungs…